Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to -$1.6 million.

  • Prothena Corp Public's Change in Accured Expenses fell 3748.95% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.5 million, marking a year-over-year increase of 5269.3%. This contributed to the annual value of -$18.3 million for FY2024, which is 18006.13% down from last year.
  • Latest data reveals that Prothena Corp Public reported Change in Accured Expenses of -$1.6 million as of Q3 2025, which was down 3748.95% from -$8.8 million recorded in Q2 2025.
  • Prothena Corp Public's 5-year Change in Accured Expenses high stood at $8.6 million for Q2 2023, and its period low was -$14.5 million during Q1 2024.
  • In the last 5 years, Prothena Corp Public's Change in Accured Expenses had a median value of $1.7 million in 2023 and averaged $337000.0.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 1107692.31% in 2023, then tumbled by 93651.62% in 2024.
  • Over the past 5 years, Prothena Corp Public's Change in Accured Expenses (Quarter) stood at $3.7 million in 2021, then crashed by 98.95% to $39000.0 in 2022, then surged by 11076.92% to $4.4 million in 2023, then plummeted by 54.32% to $2.0 million in 2024, then tumbled by 181.97% to -$1.6 million in 2025.
  • Its Change in Accured Expenses stands at -$1.6 million for Q3 2025, versus -$8.8 million for Q2 2025 and $910000.0 for Q1 2025.